The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2011

Filed:

Feb. 26, 2008
Applicants:

Kenji Kawashima, Ikoma, JP;

Hiroshi Enomoto, Ikoma, JP;

Noriko Ishizaka, Ikoma, JP;

Minoru Yamamoto, Ikoma, JP;

Kazuhiro Kudou, Ikoma, JP;

Masaaki Murai, Ikoma, JP;

Takaaki Inaba, Ikoma, JP;

Kazuyoshi Okamoto, Ikoma, JP;

Inventors:

Kenji Kawashima, Ikoma, JP;

Hiroshi Enomoto, Ikoma, JP;

Noriko Ishizaka, Ikoma, JP;

Minoru Yamamoto, Ikoma, JP;

Kazuhiro Kudou, Ikoma, JP;

Masaaki Murai, Ikoma, JP;

Takaaki Inaba, Ikoma, JP;

Kazuyoshi Okamoto, Ikoma, JP;

Assignee:

Santen Pharmaceutical Co., Ltd., Osaka-Shi, Osaka, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/497 (2006.01); A61K 31/496 (2006.01); A61K 31/454 (2006.01); A61K 31/4439 (2006.01); A61K 31/427 (2006.01); A61K 31/422 (2006.01); A61K 31/403 (2006.01); A61K 31/4025 (2006.01); A61K 31/40 (2006.01); C07D 417/12 (2006.01); C07D 413/12 (2006.01); C07D 409/04 (2006.01); C07D 405/12 (2006.01); C07D 407/10 (2006.01); C07D 401/12 (2006.01); C07D 401/04 (2006.01); C07D 403/12 (2006.01); C07D 403/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

Objects of the present invention are to study on the synthesis of a novel pyrrole derivative having a ureido group and an aminocarbonyl group as substituents or a salt thereof, to find a pharmacological effect of the derivative or a salt thereof, and to find a medicinal agent which has a prophylactic and/or therapeutic effect on a retinal disease or the like through oral administration. A compound represented by the general formula (1) or a salt thereof has an inhibitory activity against the production of interleukin-6 and/or an inhibitory effect on choroidal neovascularization, and is therefore useful as a prophylactic and/or therapeutic agent for a disease associated with interleukin-6, an ocular inflammatory disease and/or a retinal disease. In the formula, the ring A represents a benzene ring or the like; Rrepresents a halogen atom, a hydrogen atom, a lower alkyl group or the like; Rrepresents a halogen atom, a lower alkyl group which may have a substituent, a lower alkenyl group, a lower alkynyl group which may have a substituent, a lower cycloalkyl group, an aryl group, a hydroxy group, a lower alkoxy group which may have a substituent or the like; and n represents 0, 1, 2, 3 or the like.


Find Patent Forward Citations

Loading…